(Q37393024)

20 August 2017

1 reference

title

Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies (English)

1 reference

20 August 2017

1 reference

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

3

Robert L Ferris

1 reference

20 August 2017

Steve C Lee

1

1 reference

PubMed ID

19216848

20 August 2017

Andrés López-Albaitero

series ordinal

2

1 reference

20 August 2017

1 March 2009

1 reference

20 August 2017

Current Oncology Reports

1 reference

20 August 2017

11

1 reference

20 August 2017

2

1 reference

20 August 2017

156-162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-009-0023-5

20 August 2017

0 references

cites work

Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0023-5

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0023-5

Immune complex-mediated antigen presentation induces tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0023-5

Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-009-0023-5

Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31)

21 January 2018

1 reference

12 December 2020

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor

1 reference

12 December 2020

Effector and regulatory events during natural killer-dendritic cell interactions

1 reference

12 December 2020

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.

1 reference

12 December 2020

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype

1 reference

12 December 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

12 December 2020

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

12 December 2020

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

1 reference

12 December 2020

Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies

1 reference

12 December 2020

Epidermal growth factor receptor targeting in cancer

1 reference

12 December 2020

Salvage surgery after failed primary concomitant chemoradiation

1 reference

12 December 2020

FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients.

1 reference

12 December 2020

Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions.

1 reference

12 December 2020

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

12 December 2020

Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses

1 reference

12 December 2020

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

1 reference

12 December 2020

Fully human therapeutic monoclonal antibodies

1 reference

12 December 2020

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

12 December 2020

Immunobiology of head and neck cancer

1 reference

12 December 2020

Targeting angiogenesis in head and neck cancer

1 reference

12 December 2020

Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma

1 reference

12 December 2020

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy

1 reference

12 December 2020

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

12 December 2020

Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance

1 reference

12 December 2020

1 reference

12 December 2020

Monoclonal antibody mechanisms of action in cancer.

1 reference

12 December 2020

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

1 reference

12 December 2020

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

1 reference

12 December 2020

T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease

1 reference

12 December 2020

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

12 December 2020

Role of chaperones and FcgammaR in immunogenic death

1 reference

12 December 2020

Immunotherapy: past, present and future

1 reference

12 December 2020

Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor

1 reference

12 December 2020

Production of functional chimaeric mouse/human antibody

1 reference

12 December 2020

Biology of interactions: antiepidermal growth factor receptor agents

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization

1 reference

12 December 2020

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

12 December 2020

Immune activation by epidermal growth factor receptor specific monoclonal antibody therapy for head and neck cancer

1 reference

12 December 2020

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

1 reference

12 December 2020

NK cell and DC interactions

1 reference

12 December 2020

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

1 reference

12 December 2020

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

12 December 2020

Enhanced T-cell responses to glioma cells coated with the anti-EGF receptor antibody and targeted to activating FcgammaRs on human dendritic cells

1 reference

12 December 2020

10.1007/S11912-009-0023-5

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19216848